I am a medical doctor and epidemiologist with over eight years experience helping pharmaceutical, biotech, and medical device teams generate real-world evidence they can act on and defend, from the first research question to the final deliverable.

Training in both medicine and epidemiology shapes how I approach every project. The clinician in me asks whether a question matters to patients and the people treating them. The epidemiologist asks whether the data can answer it, and how to design the study so the answer can be trusted. Most of my work lives where those two questions meet.

What I bring

Study design that starts with the question
Every study begins with the therapeutic or evidence gap it needs to close. I design protocols grounded in validated methodologies and the current literature, so the question is answerable, the design is defensible, and the results speak to the decision they will inform.

Advanced methods on large-scale data
I apply advanced epidemiological and statistical methods to electronic medical records, administrative claims, and clinical registries - sources with real strengths and well-known limitations. Confounding, misclassification, and missing data are handled in the design, not patched at the end, and the methods are chosen to fit the question and the data rather than the other way round.

Delivery on scope, time, and budget
I've led projects end to end and managed external vendors - data providers, analytics partners, medical writers - to deliver high-quality outputs on time and within budget. You get one accountable point of contact and a clear view of where things stand at every stage.

Communication that lands
Findings only matter if the right people understand them. I'm used to explaining complex clinical and scientific concepts to cross-functional stakeholders - medical affairs, HEOR, market access, regulatory, commercial - and to external KOLs, in terms each audience can use, without softening the science.

Who I work with

Pharmaceutical and biotech companies, medical device manufacturers, CROs, and academic groups that need observational studies designed, executed, or critically reviewed. Typical engagements include protocol development, feasibility assessment, comparative effectiveness and safety studies, treatment-pattern and burden-of-illness analyses, epidemiological support for regulatory and HTA submissions, and independent methodological review.

Let's talk.

If you have a research question and real-world data - or need help working out whether the data can answer the question - I'd be glad to hear from you.

Get in touch below.